Zobrazeno 1 - 10
of 105
pro vyhledávání: '"M Buelli"'
Autor:
P. Bellavita, Sergio Cortelazzo, Alessandro Rambaldi, Elena Oldani, M. Buelli, Piera Viero, T Barbui, A. Rossi
Publikováno v:
Annals of Oncology. 10:427-432
Summary Background Dose intensification and autologous stem cell transplantation as front-line therapy in non-Hodgkin's lymphoma patients (NHL) is a matter for debate, although preliminary data suggest a role for it in patients at high risk of resist
Autor:
Lucia Catani, M. G. Alessio, Anna Falanga, R. Consonni, E Pogliani, L Gugliotta, Maria Benedetta Donati, R. Bassan, M Buelli, G Masera, Tiziano Barbui, L Borin
Publikováno v:
Thrombosis and Haemostasis. 64:011-016
SummaryBlast cell extracts from patients with acute non lymphoid leukemia (ANLL) express cancer procoagulant (cp). Thii factor X (FX) activator is distinct from tissue factor (TF) in that it does not require factor VII (FVII) to trigger blood coagula
Autor:
D. Berti, Michele Bonuccelli, G. De Ghetto, C. Ferretti, I. Negri, M. Buelli, M. D'Amato, L. Giacometti, R. Basana
Publikováno v:
All Days.
Abstract Reducing the development time to first oil is crucial for oil companies. especially for offshore where, often, large capital commitments are necessary. It is vital to determine the optimum development scheme quickly and efficiently. The proc
Autor:
R, Bassan, R, Raimondi, T, Lerede, A, D'emilio, M, Buelli, G, Borleri, A, Personeni, P, Bellavita, F, Rodeghiero, T, Barbui
Publikováno v:
Haematologica. 83(7)
To assess outcome of an age-adapted post-remission strategy for adult patients with acute myelogenous leukemia (AML, FAB-M3 excluded), including autologous bone marrow transplantation (ABMT) or high-dose cytarabine (HIDAC) consolidation.AML patients
Publikováno v:
Haematologica. 83(5)
High-dose cytarabine (HIDAC) and new anthracycline-type drugs (mitoxantrone, idarubicin) are the mainstay of several active regimens against relapsed and refractory acute myeloid leukemia (AML). The present study was undertaken to assess the feasibil
Autor:
A. Rossi, Gian Maria Borleri, Sergio Cortelazzo, T. Barbui, P. Viero, T. Lerede, R. Bassan, M. Buelli, P. Bellavita, Benedetto Comotti, Alessandro Rambaldi
Publikováno v:
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642719622
A combination of carboplatin plus high-dose ara-C and either mitoxantrone or idarubicin (crossover) was used in 26 adults with refractory or relapsed AML and the following high-risk features: primary refractory 38%, > 2nd relapse 23%, 1st CR 60 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::925e1ee2325ee5de92bf6cdeffa19af7
https://doi.org/10.1007/978-3-642-71960-8_136
https://doi.org/10.1007/978-3-642-71960-8_136
Autor:
L, Pagano, P, Ricci, M, Montillo, A, Cenacchi, A, Nosari, A, Tonso, L, Cudillo, A, Chierichini, C, Savignano, M, Buelli, L, Melillo, E O, La Barbera, S, Sica, S, Hohaus, A, Bonini, G, Bucaneve, A, Del Favero
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 23(3)
We retrospectively studied a consecutive series of 100 patients with acute leukemia and aspergillosis to evaluate the clinical findings and risk factors for colonization of the central nervous system (CNS) by Aspergillus species. The diagnosis of CNS
Autor:
T, Lerede, R, Bassan, A, Rossi, E, Di Bona, G, Rossi, E M, Pogliani, T, Motta, V, Torri, M, Buelli, B, Comotti, P, Viero, A, Rambaldi, S, Cortelazzo, F, Rodeghiero, T, Barbui
Publikováno v:
Haematologica. 81(5)
Adult B/L3-ALL is a rare disease subset characterized by an aggressive clinical course and a poor response to conventional adult ALL-type chemotherapy. Recent data from the GMALL Group showed that prognosis can be improved with an innovative treatmen
Autor:
P. Viero, A. Rambaldi, M. Buelli, D Fracassetti, A Rossi, R Marchioli, P. Bellavita, Tiziano Barbui, R M Marfisi, Benedetto Comotti, R. Bassan, Sergio Cortelazzo
Publikováno v:
Cancer chemotherapy and pharmacology.
Circulating progenitor cells (CPCs) mobilized from bone marrow will replace the use of bone marrow transplantation because hematopoietic reconstitution is more rapid using the former technique. We report on early and late recovery of hematopoiesis af
Publikováno v:
Haematologica. 80(3)
A critical review of the role of anthracyclines in the management of adult patients with acute lymphoblastic leukemia was performed to define current indications for their use. Major pertinent clinical series were reviewed with reference to anthracyc